as 07-26-2024 4:00pm EST
Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.
Founded: | 2020 | Country: | United States |
Employees: | N/A | City: | CARMEL |
Market Cap: | 8.5M | IPO Year: | 2023 |
Target Price: | N/A | AVG Volume (30 days): | 137.4K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.64 | EPS Growth: | N/A |
52 Week Low/High: | $0.81 - $8.37 | Next Earning Date: | 08-13-2024 |
Revenue: | $6,079,133 | Revenue Growth: | 3.73% |
Revenue Growth (this year): | 70.86% | Revenue Growth (next year): | N/A |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Vuppalanchi Deepika | SYRA | CEO | Dec 4 '23 | Buy | $1.17 | 426 | $498.42 | 426 | SEC Form 4 |
Syed Feroz | SYRA | 10% Owner | Nov 28 '23 | Buy | $1.42 | 175 | $248.50 | 1,825 | SEC Form 4 |
Syed Feroz | SYRA | 10% Owner | Nov 28 '23 | Buy | $1.36 | 200 | $272.00 | 1,650 | SEC Form 4 |
Syed Feroz | SYRA | 10% Owner | Nov 28 '23 | Buy | $1.33 | 200 | $266.00 | 1,450 | SEC Form 4 |
Syed Feroz | SYRA | 10% Owner | Nov 28 '23 | Buy | $1.34 | 320 | $428.80 | 1,250 | SEC Form 4 |
Syed Feroz | SYRA | 10% Owner | Nov 28 '23 | Buy | $1.14 | 220 | $250.80 | 930 | SEC Form 4 |
Syed Feroz | SYRA | 10% Owner | Nov 28 '23 | Buy | $1.32 | 710 | $937.20 | 710 | SEC Form 4 |
Allam Sandeep | SYRA | President and Chair | Nov 28 '23 | Buy | $1.22 | 60 | $73.20 | 60 | SEC Form 4 |
Allam Sandeep | SYRA | President and Chair | Nov 28 '23 | Buy | $1.32 | 1,145 | $1,511.40 | 1,205 | SEC Form 4 |
Allam Sandeep | SYRA | President and Chair | Nov 28 '23 | Buy | $1.29 | 398 | $513.42 | 1,603 | SEC Form 4 |
Allam Sandeep | SYRA | President and Chair | Nov 28 '23 | Buy | $1.27 | 206 | $261.62 | 1,809 | SEC Form 4 |
Allam Sandeep | SYRA | President and Chair | Nov 28 '23 | Buy | $1.30 | 193 | $250.90 | 2,002 | SEC Form 4 |
Allam Sandeep | SYRA | President and Chair | Nov 28 '23 | Buy | $1.37 | 362 | $495.94 | 2,364 | SEC Form 4 |
Allam Sandeep | SYRA | President and Chair | Nov 28 '23 | Buy | $1.40 | 425 | $595.00 | 2,789 | SEC Form 4 |
Allam Sandeep | SYRA | President and Chair | Nov 28 '23 | Buy | $1.40 | 647 | $905.80 | 3,436 | SEC Form 4 |
Allam Sandeep | SYRA | President and Chair | Nov 28 '23 | Buy | $1.31 | 294 | $385.14 | 3,730 | SEC Form 4 |
SYRA Breaking Stock News: Dive into SYRA Ticker-Specific Updates for Smart Investing
PR Newswire
2 days ago
PR Newswire
10 days ago
PR Newswire
23 days ago
PR Newswire
a month ago
PR Newswire
a month ago
PR Newswire
a month ago
GuruFocus.com
a month ago
Energy Global
a month ago
The information presented on this page, "SYRA Syra Health Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.